BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 19254961)

  • 1. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
    Ashikari-Hada S; Habuchi H; Sugaya N; Kobayashi T; Kimata K
    Glycobiology; 2009 Jun; 19(6):644-54. PubMed ID: 19254961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts.
    Delehedde M; Lyon M; Gallagher JT; Rudland PS; Fernig DG
    Biochem J; 2002 Aug; 366(Pt 1):235-44. PubMed ID: 12000311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
    Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
    Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb.
    Luo Y; Ye S; Kan M; McKeehan WL
    J Cell Biochem; 2006 Apr; 97(6):1241-58. PubMed ID: 16315317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
    Forsten-Williams K; Chua CC; Nugent MA
    J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis.
    Lundin L; Larsson H; Kreuger J; Kanda S; Lindahl U; Salmivirta M; Claesson-Welsh L
    J Biol Chem; 2000 Aug; 275(32):24653-60. PubMed ID: 10816596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs.
    Mohammadi M; Olsen SK; Goetz R
    Curr Opin Struct Biol; 2005 Oct; 15(5):506-16. PubMed ID: 16154740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the role of heparan sulphate in fibroblast growth factor signalling.
    Harmer NJ
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):442-5. PubMed ID: 16709182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides.
    Zhou FY; Kan M; Owens RT; McKeehan WL; Thompson JA; Linhardt RJ; Höök M
    Eur J Cell Biol; 1997 May; 73(1):71-80. PubMed ID: 9174673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationships.
    Rudd TR; Uniewicz KA; Ori A; Guimond SE; Skidmore MA; Gaudesi D; Xu R; Turnbull JE; Guerrini M; Torri G; Siligardi G; Wilkinson MC; Fernig DG; Yates EA
    Org Biomol Chem; 2010 Dec; 8(23):5390-7. PubMed ID: 20865198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
    Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
    Shiang CY; Qi Y; Wang B; Lazar V; Wang J; Fraser Symmans W; Hortobagyi GN; Andre F; Pusztai L
    Breast Cancer Res Treat; 2010 Oct; 123(3):747-55. PubMed ID: 20024612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
    Miao HQ; Fritz TA; Esko JD; Zimmermann J; Yayon A; Vlodavsky I
    J Cell Biochem; 1995 Feb; 57(2):173-84. PubMed ID: 7759555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.
    Moy FJ; Safran M; Seddon AP; Kitchen D; Böhlen P; Aviezer D; Yayon A; Powers R
    Biochemistry; 1997 Apr; 36(16):4782-91. PubMed ID: 9125499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural cell adhesion molecule regulates the cellular response to fibroblast growth factor.
    Francavilla C; Loeffler S; Piccini D; Kren A; Christofori G; Cavallaro U
    J Cell Sci; 2007 Dec; 120(Pt 24):4388-94. PubMed ID: 18042627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.
    Ashikari-Hada S; Habuchi H; Kariya Y; Itoh N; Reddi AH; Kimata K
    J Biol Chem; 2004 Mar; 279(13):12346-54. PubMed ID: 14707131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin differentially regulates the interaction of fibroblast growth factor-4 with FGF receptors 1 and 2.
    Aviezer D; Safran M; Yayon A
    Biochem Biophys Res Commun; 1999 Oct; 263(3):621-6. PubMed ID: 10512728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
    Foxall C; Wei Z; Schaefer ME; Casabonne M; Fugedi P; Peto C; Castellot JJ; Brandley BK
    J Cell Physiol; 1996 Sep; 168(3):657-67. PubMed ID: 8816920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.